ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers

A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp

ClinicalTrials.gov ID: NCT02611804

Public ClinicalTrials.gov record NCT02611804. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 10:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT02611804
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Teva Pharmaceuticals USA
Industry
Enrollment
492 participants

Conditions and interventions

Interventions

  • Diclofenac sodium Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2015
Primary completion
Jul 31, 2016
Completion
Jul 31, 2016
Last update posted
May 4, 2017

2015 – 2016

United States locations

U.S. sites
30
U.S. states
15
U.S. cities
26
Facility City State ZIP Site status
Agave Clinical Research Mesa Arizona 85202
Radiant Research, Inc. Tucson Arizona 85712
Center for Dermatology Clinical Research, Inc. Fremont California 94538
Medical Center for Clinical Research San Diego California 92108
TCR Medical Corporation San Diego California 92123
Clinical Science Institute Santa Monica California 90404
Horizons Clinical Research Center Denver Colorado 80220
Olympian Clinical Research Clearwater Florida 33757
Tampa Bay Medical Research Clearwater Florida 33761
Renstar Medical Research Ocala Florida 34471
DS Research Louisville Kentucky 40202
Dermatology Consulting Services High Point North Carolina 27262
DermOne of North Carolina Wilmington North Carolina 28401
PMG Research of Winston-Salem Winston-Salem North Carolina 27103
Radiant Research Cincinnati Ohio 45249
Lynn Health Science Institute Oklahoma City Oklahoma 73112
Omega Medical Research Warwick Rhode Island 02886
Radiant Research Anderson South Carolina 29621
Greenville Dermatology Greenville South Carolina 29607
Dermatology Associates of Knoxville Knoxville Tennessee 37917
The Skin Wellness Center Knoxville Tennessee 37922
Tennessee Clinical Research Center Nashville Tennessee 37215
DermResearch, Inc. Austin Texas 78759
The Center for Skin Research Houston Texas 77056
ACRC Trials Plano Texas 75024
Dermatology Clinical Research Center of San Antonio San Antonio Texas 78229
Stephen Miller, M.D. San Antonio Texas 78249
Dermatology Research Center Salt Lake City Utah 84117
The Education and Research Foundation Lynchburg Virginia 24501
Premier Clinical Research Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02611804, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 4, 2017 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02611804 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →